Maren Elise Hackbusch, PA
Physician Assistant · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 4
Offices
4 locations · Permanente Medical Group Inc · 10,928 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Maren Elise Hackbusch’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence C52544 · Cancelled
Licence status: Cancelled · since 2006 · University of Texas Medical School at Houston.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$3,880
Pharmacies billed $3,880 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 16% of their Part D prescriptions (30 of 192) in 2024. Above the middle of the specialty; the typical physician assistant clinician is at 1%.
186 generic and fewer than 11 brand-name prescriptions · $3,880 in drug cost · 72 antibiotic prescriptions to 45 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Cefpodoxime Proxetil | 13 | $587 | $45 |
| Nystatin-Triamcinolone | 15 | $492 | $29 |
| Trospium Chloride | 17 | $258 | $13 |
| Ibuprofen | 15 | $179 | $12 |
| Oxycodone | 19 | $154 | $7 |
See all 6 drugs
| Cefpodoxime Proxetil | 13 | $587 | $45 |
| Nystatin-Triamcinolone | 15 | $492 | $29 |
| Trospium Chloride | 17 | $258 | $13 |
| Ibuprofen | 15 | $179 | $12 |
| Oxycodone | 19 | $154 | $7 |
| Sulfamethoxazole-Trimethoprim | 20 | $150 | $6 |
Year by year
| 2024 | 192 | 75 | 16% (30) | None | $3,880 |
| 2023 | 200 | 87 | 14% (27) | None | $5,178 |
| 2022 | 189 | 95 | 16% (30) | None | $3,658 |
| 2021 | 103 | 46 | 22% (23) | None | $1,615 |
| 2017 | 122 | 29 | 0% (0) | 14% | $6,968 |
| 2016 | 969 | 104 | None | None | $58,112 |
| 2015 | 107 | 38 | None | None | $4,651 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Trospium Chloride | 29 | $414 | $14 |
| Ibuprofen | 19 | $247 | $13 |
| Cephalexin | 18 | $186 | $10 |
| Nitrofurantoin Mono-Macro | 11 | $168 | $15 |
| Oxycodone | 23 | $168 | $7 |
| Sulfamethoxazole-Trimethoprim | 18 | $119 | $7 |
| Ciprofloxacin | 14 | $110 | $8 |
2022: 5 drugs
| Cephalexin | 26 | $287 | $11 |
| Oxybutynin Chloride Er | 11 | $282 | $26 |
| Oxycodone | 22 | $145 | $7 |
| Sulfamethoxazole-Trimethoprim | 21 | $144 | $7 |
| Ciprofloxacin | 17 | $131 | $8 |
2021: 4 drugs
| Oxybutynin Chloride Er | 12 | $692 | $58 |
| Cephalexin | 14 | $149 | $11 |
| Oxycodone | 16 | $117 | $7 |
| Sulfamethoxazole-Trimethoprim | 15 | $95 | $6 |
2017: 4 drugs
| Lisinopril | 20 | $88 | $4 |
| Metformin | 16 | $74 | $5 |
| Omeprazole | 21 | $71 | $3 |
| Amlodipine Besylate | 12 | $27 | $2 |
2016: 22 drugs
| Lantus | 28 | $11,398 | $407 |
| Januvia | 18 | $8,903 | $495 |
| Invokana | 16 | $7,122 | $445 |
| Ventolin Hfa | 14 | $933 | $67 |
| Lisinopril | 123 | $659 | $5 |
| Gabapentin | 35 | $528 | $15 |
| Atorvastatin | 54 | $472 | $9 |
| Levothyroxine | 28 | $436 | $16 |
| Simvastatin | 42 | $400 | $10 |
| Metformin | 58 | $347 | $6 |
| Omeprazole | 28 | $296 | $11 |
| Pioglitazone | 15 | $274 | $18 |
| Amlodipine Besylate | 47 | $248 | $5 |
| Losartan | 25 | $248 | $10 |
| Hydrochlorothiazide | 58 | $226 | $4 |
| Glimepiride | 21 | $208 | $10 |
| Atenolol | 17 | $136 | $8 |
| Ibuprofen | 15 | $111 | $7 |
| Sertraline | 26 | $110 | $4 |
| Trazodone | 18 | $99 | $6 |
| Carvedilol | 16 | $71 | $4 |
| Meloxicam | 11 | $34 | $3 |
Money from drug and device companies
$70 in 2024
| 2024 | 1 | 2 | None | $70 |
| 2022 | 1 | 1 | None | $28 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Ams 700 | $70 | 2 payments
|
See all 2 published payments
| Boston Scientific | Meals · 2024-10-17 | Ams 700 | $41 |
| Boston Scientific | Meals · 2024-01-19 | Ams 700 | $29 |
See earlier years (2022)
2022: $28
| Boston Scientific | General - Erectile Dysfunction | $28 | 1 payment
|
Professional record
- NPI
- 1932580362
- Licence
- CA 52544California C52544: Cancelled
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 1691 the Alameda, San Jose, CA, 95126
- NPI first listed
- 2015-06-11
- NPI last updated
- 2022-01-03
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.